186
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Point Prevalence Survey of Antimicrobial Use in Four Tertiary Care Hospitals in Mexico

, , ORCID Icon, , , , , ORCID Icon & show all
Pages 4553-4566 | Published online: 02 Nov 2021

References

  • Holmes AH, Moore LSP, Sundsfjord A, et al. Understanding the mechanisms and drivers of antimicrobial resistance. Lancet. 2016;387(10014):176–187. doi:10.1016/S0140-6736(15)00473-026603922
  • Founou RC, Founou LL, Essack SY. Clinical and economic impact of antibiotic resistance in developing countries: a systematic review and meta-analysis. PLoS One. 2017;12(12):1–18. doi:10.1371/journal.pone.0189621
  • Gulen TA, Guner R, Celikbilek N, Keske S, Tasyaran M. Clinical importance and cost of bacteremia caused by nosocomial multi drug resistant Acinetobacter baumannii. Int J Infect Dis. 2015;38:32–35. doi:10.1016/j.ijid.2015.06.01426129972
  • Centres for Disease Control and Prevention UD of H and HS. Antibiotic Resistance: A Global Threat. World Health Organization; 2013.
  • O’Neil J. Review on antibiotic resistance. Antimicrobial resistance: tackling a crisis for the health and wealth of nations. Health Wealth Nations. 2014;(December):1–16.
  • World Health Organization. Global action plan on antimicrobial resistance; 2015. Available from: https://www.who.int/iris/bitstream/10665/193736/1/9789241509763_eng.pdf?ua=1. Accessed October 20, 2021.
  • Fridkin S, Baggs J, Fagan R, et al. Vital signs: improving antibiotic use among hospitalized patients. MMWR Morb Mortal Wkly Rep. 2014;63(9):194–200.24598596
  • Tamma PD, Avdic E, Li DX, Dzintars K, Cosgrove SE. Association of adverse events with antibiotic use in hospitalized patients. JAMA Intern Med. 2017;177(9):1308–1315. doi:10.1001/jamainternmed.2017.193828604925
  • Marchaim D, Chopra T, Bhargava A, et al. Recent exposure to antimicrobials and carbapenem-resistant Enterobacteriaceae: the role of antimicrobial stewardship. Infect Control Hosp Epidemiol. 2012;33(8):817–830. doi:10.1086/66664222759550
  • Paterson DL. “Collateral damage” from cephalosporin or quinolone antibiotic therapy. Clin Infect Dis. 2004;38(Suppl4):341–345. doi:10.1086/382690
  • Rice LB. Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE. J Infect Dis. 2008;197(8):1079–1081. doi:10.1086/53345218419525
  • Davey P, Marwick CA, Scott CL, et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev. 2017;(2):Art. No.: CD003543. doi:10.1002/14651858.CD003543.pub4
  • Wirtz VJ, Dreser A, Gonzales R. Trends in antibiotic utilization in eight Latin American countries, 1997–2007. Rev Panam Salud Publica/Pan Am J Public Health. 2010;27(3):219–225. doi:10.1590/S1020-49892010000300009
  • Huerta-Gutiérrez R, Braga L, Camacho-Ortiz A, et al. One-day point prevalence of healthcare-associated infections and antimicrobial use in four countries in Latin America. Int J Infect Dis. 2019;86:157–166. doi:10.1016/j.ijid.2019.06.01631229613
  • Aguilar-Rodea B, Cureño-Diaz M, Alvarez-Montero F, Valdes-Castro R, Valdez-Vázquez R, Figueroa-Moreno R. Epidemiology of healthcare-associated infections at a General Hospital in Mexico City: 2013–2014. Open Forum Infect Dis. 2015;2(suppl_1). doi:10.1093/ofid/ofv133.1269
  • Garza-González E, Morfín-Otero R, Mendoza-Olazarán S, et al. A snapshot of antimicrobial resistance in Mexico. Results from 47 centers from 20 states during a six-month period. PLoS One. 2019;14(3):1–13. doi:10.1371/journal.pone.0209865
  • Miranda-Novales MG, Flores-Moreno K, López-Vidal Y, et al. Antimicrobial resistance and antibiotic consumption in Mexican hospitals. Salud Publica Mex. 2020;62(1):42–49.31869560
  • Álvarez de Iturbe I, Chirino-Barceló Y, López López A, Zamorano Jiménez CA, Nava Frías M. Uso de la profilaxis antimicrobiana en el Departamento de Cirugía en un hospital de tercer nivel de atención. An Med. 2013;58(4):247–252.
  • Solís-Téllez H, Mondragón-Pinzón EE, Ramírez-Marino M, et al. Epidemiologic analysis: prophylaxis and multidrug-resistance in surgery. Rev Gastroenterol México. 2017;82(2):115–122. doi:10.1016/j.rgmxen.2016.12.002
  • Palacios-Saucedo G Del C, de la Garza-camargo M, Briones-Lara E, et al. Evaluación del uso de antibióticos e impacto de una intervención dirigida a modificar la conducta prescriptiva en profilaxis quirúrgica en 6 hospitales del área metropolitana de Monterrey. Cir Cir. 2017;85(6):459–470. doi:10.1016/j.circir.2016.10.03328063606
  • Ansari F, Erntell M, Goossens H, Davey P. The European surveillance of antimicrobial consumption (ESAC) point-prevalence survey of antibacterial use in 20 European hospitals in 2006. Clin Infect Dis. 2009;49(10):1496–1504. doi:10.1086/64461719842976
  • Zarb P, Amadeo B, Muller A, et al. Identification of targets for quality improvement in antimicrobial prescribing: the web-based ESAC point prevalence survey 2009. J Antimicrob Chemother. 2011;66(2):443–449. doi:10.1093/jac/dkq43021084362
  • Versporten A, Zarb P, Caniaux I, et al. Antimicrobial consumption and resistance in adult hospital inpatients in 53 countries: results of an internet-based global point prevalence survey. Lancet Glob Health. 2018;6(6):e619–e629. doi:10.1016/S2214-109X(18)30186-429681513
  • World Health Organization. WHO methodology for point prevalence survey on antibiotic use in hospitals, version 1.1; 2018. Available from: https://www.who.int/medicines/access/antimicrobial_resistance/WHO-EMP-IAU-2018_01/en/. Accessed October 20, 2021.
  • Zumaya-Estrada FA, Alpuche-Aranda CM, Saturno-Hernandez PJ. The WHO methodology for point prevalence surveys on antibiotics use in hospitals should be improved: lessons from pilot studies in four Mexican hospitals. Int J Infect Dis. 2021;108:13–17. doi:10.1016/j.ijid.2021.04.07933932602
  • World Health Organization. International language for drug utilization research; 2020. Available from: https://www.whocc.no/. Accessed October 20, 2021.
  • IBM. IBM SPSS statistics for windows; 2017.
  • GraphPad. GraphPad QuickCalcs; 2021. Available from: https://www.graphpad.com/quickcalcs/confInterval1//. Accessed October 20, 2021.
  • Magill SS, Edwards JR, Beldavs ZG, et al. Prevalence of antimicrobial use in us acute care hospitals, May–September 2011. JAMA. 2014;312(14):1438–1446. doi:10.1001/jama.2014.1292325291579
  • Soria-Orozco M, Padrón-Salas A, González-mercado J de J, et al. Prevalencia de uso de antimicrobianos entre pacientes hospitalizados en áreas no críticas en un hospital universitario de México. Salud Publica Mex. 2017;59(5):504–505. doi:10.21149/846529267640
  • Porto APM, Goossens H, Versporten A, Costa SF. Global point prevalence survey of antimicrobial consumption in Brazilian hospitals. J Hosp Infect. 2020;104(2):165–171. doi:10.1016/j.jhin.2019.10.01631678430
  • World Health Organization. The 2019 WHO AWaRe classification of antibiotics for evaluation and monitoring of use; 2019. Available from: https://www.who.int/publications/i/item/WHOEMPIAU2019.11. Accessed October 20, 2021.
  • Bratzler DW, Dellinger EP, Olsen KM, et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Am J Health Pharm. 2013;70(3):195–283. doi:10.2146/ajhp120568
  • Lakbar I, De Waele JJ, Tabah A, Einav S, Martin-Loeches I, Leone M. Antimicrobial de-escalation in the ICU: from recommendations to level of evidence. Adv Ther. 2020;37(7):3083–3096. doi:10.1007/s12325-020-01390-232462606
  • Rawat D, Nair D. Extended-spectrum β-lactamases in gram negative bacteria. J Glob Infect Dis. 2010;2(3):263–274. doi:10.4103/0974-777X.6853120927289
  • Garza-González E, Bocanegra-Ibarias P, Bobadilla-Del-Valle M, et al. Drug resistance phenotypes and genotypes in Mexico in representative gram-negative species: results from the infivar network. PLoS One. 2021;16(3):e0248614. doi:10.1371/journal.pone.024861433730101
  • CDC. The core elements of hospital antibiotic stewardship programs: 2019; 2019. Available from: https://www.cdc.gov/antibiotic-use/core-elements/hospital.html. Accessed October 20, 2021.
  • Wagner B, Filice GA, Drekonja D, et al. Antimicrobial stewardship programs in inpatient hospital settings: a systematic review. Infect Control Hosp Epidemiol. 2014;35(10):1209–1228. doi:10.1086/67805725203174
  • Karanika S, Paudel S, Grigoras C, Kalbasi A, Mylonakis E. Systematic review and meta-analysis of clinical and economic outcomes from the implementation of hospital-based antimicrobial. Antimicrob Agents Chemother. 2016;60(8):4840–4852. doi:10.1128/AAC.00825-1627246783
  • Barlam TF, Cosgrove SE, Abbo LM, et al. Implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis. 2016;62:51–77. doi:10.1093/cid/ciw118
  • World Health Organization. Antimicrobial stewardship programmes in health-care facilities in low- and middle-income countries. A practical toolkit. 2019.
  • Wilkinson A, Ebata A, Macgregor H. Interventions to reduce antibiotic prescribing in LMICs: a scoping review of evidence from human and animal health systems. Antibiotics. 2019;8(1). doi:10.3390/antibiotics8010002
  • Oliveira I, Rego C, Semedo G, et al. Systematic review on the impact of guidelines adherence on antibiotic prescription in respiratory infections. Antibiotics. 2020;9(9):1–19. doi:10.3390/antibiotics9090546
  • Segala FV, Murri R, Taddei E, et al. Antibiotic appropriateness and adherence to local guidelines in perioperative prophylaxis: results from an antimicrobial stewardship intervention. Antimicrob Resist Infect Control. 2020;9(1):1–6. doi:10.1186/s13756-020-00814-631908772
  • Vercheval C, Gillet M, Maes N, et al. Quality of documentation on antibiotic therapy in medical records: evaluation of combined interventions in a teaching hospital by repeated point prevalence survey. Eur J Clin Microbiol Infect Dis. 2016;35(9):1495–1500. doi:10.1007/s10096-016-2690-027255220